Did you mean benzophenone-3 3 3 3 and hydroquinone?
Displaying drugs 15751 - 15775 of 15867 in total
4-(2-aminoethyl)-2-ethylphenol
Experimental
Bromamphenicol
Experimental
Decyl(dimethyl)phosphine oxide
Experimental
(S)-econazole
Experimental
(1R)-1,2,2-trimethylpropyl (R)-methylphosphinate
Experimental
4-(2-HYDROXYPHENYLSULFINYL)-BUTYLPHOSPHONIC ACID
Experimental
5-(PARA-NITROPHENYL PHOSPHONATE)-PENTANOIC ACID
Experimental
phenyl ethenesulfonate
Experimental
Nicarbazin
Vet approved
Sulfanitran
Vet approved
Tulobuterol
Tulobuterol has been used in trials studying the treatment of Chronic Obstructive Pulmonary Disease.
Investigational
Matched Salts cas: … 56776-01-3 …
Mavatrep
Mavatrep has been used in trials studying the treatment of Osteoarthritis, Knee.
Investigational
Benzododecinium
Benzododecinium is used as an antiseptic/disinfectant compound. It has been marketed as a tincture for antiseptic product for wounds in the Czech Republic.
Experimental
Guanoxabenz
Experimental
Bifemelane
Experimental
Fenoxazoline
Experimental
Myristalkonium
Experimental
Lortalamine
Lortalamine (LM-1404) is a selective norepinephrine reuptake inhibitor developed in the 1980s. This drug never made it past clinical trials, likely due to ocular toxicity in animals, but has been used in positron emission tomography studies to label norepinephrine transporters.
Experimental
Roluperidone
Roluperidone has been used in trials studying the treatment of Schizophrenia.
Investigational
Bisegliptin
Bisegliptin is a compound for the treatment of type 2 diabetes. It is an orally active, dipeptidyl peptidase-IV (DPPIV) inhibitor which lowers blood glucose levels by blocking the degradation of the hormone GLP-1 thereby stimulating glucose-dependent insulin secretion and lowering blood glucose levels without hypoglycemic effects.
Investigational
Matched Description: … blocking the degradation of the hormone GLP-1 thereby stimulating glucose-dependent insulin secretion and …
N-(2-hydroxybenzyl)-2,5-dimethoxy-4-cyanophenylethylamine
25CN-NBOH (N-(2-hydroxybenzyl)-2,5-dimethoxy-4-cyanophenylethylamine) is a newly developed selective 5-HT2A agonist. It has been tested with regard to the head-twitch-response (HTR) model of 5-HT2A activity and effects on locomotion . It was discovered in 2014 at the University of Copenhagen.
Experimental
Matched Description: … It has been tested with regard to the head-twitch-response (HTR) model of 5-HT2A activity and effects …
Displaying drugs 15751 - 15775 of 15867 in total